SavedAdd your journal

Journals / Namık Kemal Tıp Dergisi / 2022 / Cilt: 10 - Sayı: 1

The Effect of Vulvar Lichen Sclerosus on Urogynecological Functions in Postmenopausal Women

Postmenopozal Kadınlarda Vulvar Liken Sklerozun Ürojinekolojik Fonksiyonlara Etkisi

Sema KARAKAŞ
Şükrü YILDIZ
Levent YAŞAR
Pages
48–52
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Total UDI-6 scores were significantly higher in the study group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To examine the relationship between urinary symptoms and vulvar lichen sclerosus.
📊
Key Findings & Data:Materials and Methods: This cross-sectional study was performed in our clinic between January 2019 and March 2020.
💡
Conclusion & Impact:Total UDI-6 scores were significantly higher in the study group (p
🔬Design:Survey & Empirical Study
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: To examine the relationship between urinary symptoms and vulvar lichen sclerosus. Materials and Methods: This cross-sectional study was performed in our clinic between January 2019 and March 2020. One hundred and ten patients were included in the study. They were all postmenopausal women and were divided into two groups: the study group comprised of women diagnosed with lichen sclerosus (n=59), and the control group comprised of postmenopausal women who sought a routine gynecological examination (n=51). In the study group, all patients were dermatopathologically diagnosed with biopsy. Both groups completed two validated questionnaires: the Urogenital Distress Inventory (UDI-6) and the Incontinence Impact Questionnaire (IIQ-7). The total scores from questionnaires and sub-groups of UDI-6 and IIQ-7 were also analyzed in detail. Results: There were no differences in demographic features or in time from the onset of menopause for both groups. Total UDI-6 scores were significantly higher in the study group (p

Özet

Amaç: Üriner semptomlar ile vulvar liken skleroz arasındaki ilişkiyi incelemektir. Gereç ve Yöntem: Bu kesitsel çalışma Ocak 2019 ile Mart 2020 tarihleri arasında kliniğimizde yapılmıştır. Çalışmaya 110 hasta dahil edildi. Hepsi postmenopozal kadınlardan oluşan hastalar iki gruba ayrıldı. Çalışma grubu liken skleroz tanısı alan kadınlardan (n=59) ve kontrol grubu rutin jinekolojik muayene isteyen menopoz sonrası kadınlardan (n=51) oluşuyordu. Çalışma grubundaki tüm hastalara dermatopatolojik olarak biyopsi ile tanı konuldu. Her iki grup da valide edilmiş Ürogenital Sıkıntı Envanteri (UDI-6) ve İnkontinans Etki Anketi (IIQ-7) anketlerini doldurdu. UDI-6 ve IIQ-7’nin anket ve alt gruplarından alınan toplam puanlar analiz edildi. Bulgular: Her iki grup için demografik özelliklerde veya menopoz başlangıcından bu yana geçen sürede fark yoktu. Toplam UDI-6 puanları çalışma grubunda anlamlı olarak daha yüksekti (p

🔖

Cite This Article

KARAKAŞ, S., YILDIZ, Ş., YAŞAR, L. (2022). The Effect of Vulvar Lichen Sclerosus on Urogynecological Functions in Postmenopausal Women. Namık Kemal Tıp Dergisi, Cilt: 10 - Sayı: 1, 48–52. https://ajindex.com/articles/584036

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Thomas RH, Ridley CM, McGibbon DH, Black MM. Anogenital lichen sclerosus in women. J R Soc Med. 1996;89:694-8
  2. Bleeker MC, Visser PJ, Overbeek LI, van Beurden M, Berkhof J. Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma. Cancer Epidemiol Biomarkers Prev. 2016;25:1224-30
  3. Regauer S. Immune dysregulation in lichen sclerosus. Eur J Cell Biol. 2005;84:273-7
  4. Berger MB, Damico NJ, Menees SB, Fenner DE, Haefner HK. Rates of selfreported urinary, gastrointestinal, and pain comorbidities in women with vulvar lichen sclerosus. J Low Genit Tract Dis. 2012;16:285-9
  5. Christmann-Schmid C, Hediger M, Gröger S, Krebs J, Günthert AR; In cooperation with the Verein Lichen sclerosus. Vulvar lichen sclerosus in women is associated with lower urinary tract symptoms. Int Urogynecol J. 2018;29:217-21
  6. Hasegawa M, Ishikawa O, Asano Y, Sato S, Jinnin M, Takehara K, et al. Diagnostic criteria, severity classification and guidelines of lichen sclerosus et atrophicus. J Dermatol. 2018;45:891-7
  7. Cam C, Sakalli M, Ay P, Cam M, Karateke A. Validation of the short forms of the incontinence impact questionnaire (IIQ-7) and the urogenital distress inventory (UDI-6) in a Turkish population. Neurourol Urodyn. 2007;26:129- 33
  8. Kennedy CM, Nygaard IE, Bradley CS, Galask RP. Bladder and bowel symptoms among women with vulvar disease: are they universal? J Reprod Med. 2007;52:1073-8
  9. Neill SM, Lewis FM, Tatnall FM, Cox NH; British Association of Dermatologists. British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010. Br J Dermatol. 2010;163:672-82
  10. Pinelli S, D’Erme AM, Lotti T. Management of sexual dysfunction due to vulvar lichen sclerosus in postmenopausal women. Dermatol Ther. 2013;26:79-82
  11. Burrows LJ, Creasey A, Goldstein AT. The treatment of vulvar lichen sclerosus and female sexual dysfunction. J Sex Med. 2011;8:219-22
  12. Van de Nieuwenhof HP, Meeuwis KA, Nieboer TE, Vergeer MC, Massuger LF, De Hullu JA. The effect of vulvar lichen sclerosus on quality of life and sexual functioning. J Psychosom Obstet Gynaecol. 2010;31:279-84
  13. Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol. 2008;144:1432-5
  14. Thorstensen KA, Birenbaum DL. Recognition and management of vulvar dermatologic conditions: lichen sclerosus, lichen planus, and lichen simplex chronicus. J Midwife